Source link : https://newshealth.biz/health-news/novel-therapies-for-hidradenitis-suppurativa-produce-rapid-deepening-responses/
DENVER — Two therapeutic candidates for severe hidradenitis suppurativa (HS) achieved major responses that proved durable in randomized trials reported here. The IL-17A/F inhibitor sonelokimab achieved at least 75% skin clearance (HiSCR 75) at 40 weeks in 62% of patients enrolled in identical phase III clinical trials. Two different doses of the oral JAK1 inhibitor […]
The post Novel Therapies for Hidradenitis Suppurativa Produce Rapid, Deepening Responses first appeared on News Health.
—-
Author : News Health
Publish date : 2026-04-03 21:13:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8